Independent fund research. Built on SEC filings.

How we research funds

ETF · Technology Sector · Spinnaker

Langar Global HealthTech ETF (LGHT)

Ticker LGHT · Since 2024-01-09 · · Holdings as of Jun 30, 2026

Expense ratio
0.85%$85/yr per $10k
1-yr return
−1.5%as of Dec 2025
Net assets
$2.5Mall share classes
Holdings
29

Bottom line

Is LGHT a good fund? The bottom line

LGHT is a managed technology sector ETF from Spinnaker.

Its expense ratio is 0.85% — about $85 a year on every $10,000 invested, more expensive than 58% of technology sector funds we track.

It returned −1.5% over one year (as of Dec 31, 2025, per its prospectus).

With $2.5 million in net assets and 29 holdings, its largest position is Umb Money Market (16.8%) and the top 10 make up 72.9% of the portfolio.

What to watch

  • Concentrated: top 10 holdings are 72.9% of assets
  • Small fund ($2.5 million) — small funds are likelier to close

Updated Nov 19, 2026

What LGHT invests in

Langar Global HealthTech ETF (the Fund) seeks long-term growth of capital.

As an actively managed exchange-traded fund (ETF), the Fund will not seek to replicate the performance of an index. The Fund intends to achieve its investment objective by investing a majority of its net assets in U.S. and foreign exchange-listed healthcare technology companies in the U.S and a number of developed countries around the world. Under normal circumstances, the Fund will invest at least 80% of the Funds net assets (plus borrowings for investment purposes) in U.S. and foreign exchange-listed equity securities of healthcare technology companies and American Depository Receipts (ADRs) on those securities. These securities may be of any market capitalization. Langar Investment Management, LLC (the Advisor) uses a combination of a top-down review and a bottom-up research methodology to select fundamentally strong companies that develop technology to create efficiency in…

From the fund's prospectus (filed Apr 30, 2026).

LGHT performance

Fund calendar-year total returns, 2025–2025 2025: −1.2% −1.2% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
LGHT−1.5%——
Technology Sector median+24.0%+10.0%+16.7%

Source: Fund prospectus, as of Dec 31, 2025

Full LGHT performance history →

What LGHT costs

On a $10,000 investment, LGHT's 0.85% expense ratio costs about $85 a year. The prospectus estimates $1,049 in total costs over 10 years (assuming 5% annual returns). The median technology sector fund charges 0.75%.

See the full LGHT fee table →

LGHT top 10 holdings

#Holding% of fund
1Umb Money Market16.83%
2Intuitive Surgical I9.92%
3ResMed Inc9.11%
4Moderna Inc7.98%
5Veeva Systems Inc5.60%
6GE HealthCare5.41%
7IQVIA Holdings Inc4.98%
8Koninklijke Philips4.62%
9Insulet Corp4.44%
10Dexcom Inc Com4.01%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 72.9% of the fund. See all top 25 holdings and asset mix →

Alternatives to LGHT

More funds like LGHT →

LGHT FAQ

What is the expense ratio of LGHT?
LGHT's expense ratio is 0.85%, which works out to about $85 a year for every $10,000 invested. The prospectus estimates total costs of $1,049 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is LGHT a good investment?
It depends on your goals, but the data points to: concentrated: top 10 holdings are 72.9% of assets; small fund ($2.5 million) — small funds are likelier to close. This is general information, not personalized advice.
What does LGHT hold?
LGHT's largest holdings are Umb Money Market (16.8%), Intuitive Surgical I (9.9%), ResMed Inc (9.1%), Moderna Inc (8.0%), Veeva Systems Inc (5.6%). It holds 29 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Who manages LGHT?
LGHT is offered by Spinnaker through Spinnaker ETF Series.